Icosavax Total Current Liabilities

Icosavax (ICVX) currently reports a total current liabilities of $13M as of September 2023. That compares with $13M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Icosavax's total current liabilities history and peer comparisons.

Icosavax's total current liabilities was unchanged from $13M to $13M — essentially flat versus a year earlier (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Icosavax reported $13M in total current liabilities as of September 2023. That compares with $13M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Icosavax, and consider following ICVX for alerts when major investors trade the stock.

Icosavax is classified in the Healthcare sector. On total current liabilities, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ICVX with unrelated industries.